Citizens’ Summit Contra CETA: It’s Not Only Wallonia 20/10/2016 by Intellectual Property Watch 1 Comment With the vote on the European Union-Canada trade agreement (CETA) on the agenda once more at the upcoming EU Council meeting tomorrow the representatives of European and Canadian cities and regions gathered at Brussels today for a “CETA Citizens’ Summit.” Gerardo Pisarello, vice mayor of the city of Barcelona, said that cities like his see CETA as a barrier to their plans to remunicipalize water and energy services and the attempts “to open up public procurement to small companies and cooperatives.”
UNICEF Tender Allows Gavi To Supply Vaccines For Millions Of Children 20/10/2016 by Intellectual Property Watch 1 Comment Gavi, the vaccine alliance, announced yesterday that a UNICEF pentavalent vaccine tender will secure sufficient supplies for the next three years to protect millions of children in Gavi-supported and transitioning countries.
Eli Lilly Commits To Healthcare For 30 Million People In Middle-Income Countries And US By 2030 18/10/2016 by Intellectual Property Watch Leave a Comment Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.
WHO Pandemic Influenza Advisory Group Meeting In Secret This Week 18/10/2016 by Intellectual Property Watch 1 Comment The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.
55 Civil Society Groups Ask US Government To Allow Export Of Affordable Version Of Prostate Cancer Drug Xtandi 17/10/2016 by Intellectual Property Watch 1 Comment A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.
Facebook Crowned Privacy Villain Of 2016 By European Privacy Rights Group 07/10/2016 by Intellectual Property Watch 2 Comments A European civil society group defending rights and freedoms in the digital environment awarded Facebook the Belgian Big Brother Awards 2016 yesterday.
Partial Revocation Of EPO Patent On Sofosbuvir, Key For Hepatitis C 05/10/2016 by Intellectual Property Watch 4 Comments Following a public hearing at its headquarters in Munich, the European Patent Office (EPO) decided to reject in part the arguments made by Gilead Sciences to uphold their patent on sofosbuvir, according to a non-profit group.
WIPO Conference Archive Missing Video Critical Of Artificial Intelligence, Social Media Giants 05/10/2016 by Intellectual Property Watch Leave a Comment This morning at the World Intellectual Property Organization General Assemblies, WIPO Director General Francis Gurry commented on the success of the WIPO Conference on the Global Digital Content Market, which took place in April. But the full video of the keynote speaker, who had sharp words for corporate internet giants and other new technologies, is missing from the archive.
Nagoya Protocol Gains Members, Implications Spread Ripples 22/09/2016 by Intellectual Property Watch Leave a Comment The UN Convention on Biological Diversity (CBD) announced early this month that five new countries ratified its protocol on access and benefit sharing of genetic resources, bringing membership to 85 countries.
Mass Protests Against TTIP, CETA In Germany 17/09/2016 by Intellectual Property Watch 2 Comments In Berlin, Hamburg and five other cities in Germany, some 320,000 citizens today protested against the adoption of the Comprehensive Economic and Trade Agreement (CETA) and the Trans-Atlantic Trade and Investment Partnership (TTIP).